Testimony And Official Submissions

For PhRMA legal matters, the depository below contains various testimony and official submissions:

2012-04-26
Testimony of Roy F. Waldron on behalf of PhRMA regarding International Patent Issues: Promoting A Level Playing Field For American Industry Abroad

2012-04-18
PhRMA Testimony at Energy & Commerce Health Hearing on FDA User Fees (PDUFA-V, BPCA, PREA)

2012-02-01
PhRMA Written Testimony at Energy & Commerce Health Hearing on PDUFA-V

2011-10-24
PhRMA Statement Regarding Reauthorization of the Prescription Drug User Fee Act (PDUFA-V)

2011-10-03
PhRMA Report for the Institute of Medicine Challenges and Successes in Neonatal Drug Development

2011-09-14
PhRMA Statement Before the U.S. Senate Committee on Health, Education, Labor and Pensions

2011-04-28
Pharmaceutical Research and Manufacturers of America Testimony Before the Institute of Medicine Committee on Pediatric Studies Conducted Under BPCA and PREA

2011-04-28
PhRMA Statement Before the Institute of Medicine Committee on Pediatric Studies

2009-07-29
PhRMA Statement Before U.S. Senate Special Committee On Aging

2009-06-24
Jeff Francer Before FDA Transparency Task Force